516 related articles for article (PubMed ID: 18420778)
1. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Lebrun C; Debouverie M; Vermersch P; Clavelou P; Rumbach L; de Seze J; Wiertlevski S; Defer G; Gout O; Berthier F; Danzon A
Mult Scler; 2008 Apr; 14(3):399-405. PubMed ID: 18420778
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
Achiron A; Barak Y; Gail M; Mandel M; Pee D; Ayyagari R; Rotstein Z
Breast Cancer Res Treat; 2005 Feb; 89(3):265-70. PubMed ID: 15754125
[TBL] [Abstract][Full Text] [Related]
3. Current disease-modifying therapies in multiple sclerosis.
Kieseier BC; Hartung HP
Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
[TBL] [Abstract][Full Text] [Related]
4. Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France.
Lebrun C; Debouverie M; Jeannin S; Pittion-Vouyovitch S; Bayreuther C; Berthier F
Mult Scler; 2008 Aug; 14(7):933-9. PubMed ID: 18573824
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk among patients with multiple sclerosis and their parents.
Bahmanyar S; Montgomery SM; Hillert J; Ekbom A; Olsson T
Neurology; 2009 Mar; 72(13):1170-7. PubMed ID: 19332695
[TBL] [Abstract][Full Text] [Related]
6. No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Le Bouc R; Zéphir H; Majed B; Vérier A; Marcel M; Vermersch P
Mult Scler; 2012 Jan; 18(1):55-63. PubMed ID: 21844065
[TBL] [Abstract][Full Text] [Related]
7. Cancer profile in eastern Rajasthan.
Sharma RG; Ajmera R; Saxena O
Indian J Cancer; 1994 Sep; 31(3):160-73. PubMed ID: 8557294
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis and cancers in Croatia--a possible protective role of the "Mediterranean diet".
Materljan E; Materljan M; Materljan B; Vlacić H; Barićev-Novaković Z; Sepcić J
Coll Antropol; 2009 Jun; 33(2):539-45. PubMed ID: 19662776
[TBL] [Abstract][Full Text] [Related]
9. Non-specific immunosuppressants in the treatment of multiple sclerosis.
Confavreux C; Vukusic S
Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781
[TBL] [Abstract][Full Text] [Related]
10. [The cancer registry at the Hôtel Dieu de France Hospital].
Ghosn M; Tannous R; Gedeon E
J Med Liban; 1992; 40(1):4-10. PubMed ID: 1339874
[TBL] [Abstract][Full Text] [Related]
11. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
[TBL] [Abstract][Full Text] [Related]
12. Multiple cancer--an epidemiologic exercise in Finland.
Teppo L; Pukkala E; Saxén E
J Natl Cancer Inst; 1985 Aug; 75(2):207-17. PubMed ID: 3860679
[TBL] [Abstract][Full Text] [Related]
13. [Female genital and breast cancers in France: geographic distribution and estimation of incidence].
Chaplain G; Grosclaude P; Arveux P; Raverdy N; Menegoz F; Henry-Amar M; Schaffer P; Daures JP; de Vathaire F
Bull Cancer; 1997 Oct; 84(10):935-40. PubMed ID: 9435794
[TBL] [Abstract][Full Text] [Related]
14. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
15. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
16. [Descriptive epidemiology of gynecologic and breast cancers].
Schraub S; Alauzet E; Schaffer P; Robillard J; Menegoz F
Rev Fr Gynecol Obstet; 1992 Dec; 87(12):577-85. PubMed ID: 1485074
[TBL] [Abstract][Full Text] [Related]
17. [The occurrence of malignancies in a Hungarian lupus population].
Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
[TBL] [Abstract][Full Text] [Related]
18. Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study.
Nielsen NM; Westergaard T; Frisch M; Rostgaard K; Wohlfahrt J; Koch-Henriksen N; Melbye M; Hjalgrim H
Arch Neurol; 2006 Jul; 63(7):1001-4. PubMed ID: 16831970
[TBL] [Abstract][Full Text] [Related]
19. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
20. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women.
Jensen A; Sharif H; Olsen JH; Kjaer SK
Am J Epidemiol; 2008 Jul; 168(1):49-57. PubMed ID: 18448441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
